Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532200) titled 'SCN9A Gene Expression and Inflammatory Cytokines' on April 8.

Study Type: Observational [Patient Registry]

Primary Sponsor: Jamia Millia Islamia

Condition: Pulpitis - Irreversible

Intervention: Procedure: Inferior Alveolar Nerve Block

Recruitment Status: Not recruiting

Date of First Enrollment: April 10, 2026

Target Sample Size: 100

Countries of Recruitment: India

To know more, visit https://clinicaltrials.gov/study/NCT07532200

Disclaimer: Curated by HT Syndication....